Mayo Clinic Trustees Welcome New Board Member
Mary Sue Coleman, Ph.D.
JACKSONVILLE, Fla. — The Mayo Clinic Board of Trustees welcomed Mary Sue Coleman, Ph.D., as a new public member at its quarterly meeting today.
Dr. Coleman is president emeritus of the University of Michigan, (U-M) an institution she led for 12 years before retiring in July 2014. Time magazine named her one of the nation’s “10 best college presidents,” and the American Council on Education honored her with its Lifetime Achievement Award. She previously was president of the University of Iowa.
As University of Michigan president, Dr. Coleman unveiled several major initiatives designed to impact on future generations of students, the intellectual life of the campus, and society at large. The initiatives focused on the interdisciplinary richness of the U-M, student residential life, the economic vitality of the state and nation, global engagement and the value of innovation and creativity. President Obama chose Dr. Coleman to help launch the Advanced Manufacturing Partnership, a national effort bringing together industry, universities and the federal government.
Click here for a bio of Dr. Mary Sue Coleman.
MEDIA CONTACT: Karl Oestreich, Mayo Clinic Public Affairs, 507-284-5005, newsbureau@mayo.edu.
Dr. Coleman also serves in these national higher education leadership positions:
- Co-chair of the Lincoln Project, an initiative of the American Academy of Arts & Sciences to preserve the strength and diversity of public research universities. She also serves on the Board of Trustees of the Society for Science & the Public, a nonprofit organization dedicated to public engagement in scientific research and education.
- Member of the Board of Trustees of the Kavli Foundation, advancing science and support for scientists.
- Member of the Board of Trustees of the Gates Cambridge Scholars, a graduate student fellowship program.
Dr. Coleman serves on the NIH Advisory Committee to the Director and on the boards of directors of Johnson & Johnson and the Meredith Corp.
As a biochemist, Dr. Coleman built a distinguished research career through her research on the immune system and malignancies. At U-M, she holds appointments of professor emeritus of biological chemistry in the Medical School and professor emeritus of chemistry in the College of Literature, Science, and the Arts.
For 19 years she was a member of the biochemistry faculty at the University of Kentucky. Her work in the sciences led to administrative appointments at the University of North Carolina at Chapel Hill and the University of New Mexico, where she served as provost and vice president for academic affairs. From 1995 to 2002, Dr. Coleman led the University of Iowa.
The Mayo Clinic Board of Trustees, a 31-member group of public representatives and Mayo Clinic physicians and administrators, is responsible for patient care, medical education and research at Mayo Clinic’s sites in Jacksonville; Rochester, Minnesota.; and Phoenix and Scottsdale, Arizona.
###
About Mayo Clinic
Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visitwww.mayoclinic.com and www.mayoclinic.org/news.